UnknownNCT05145348

Prospective Monitoring of Antibody Response Following COVID-19 Vaccination in Patients With Down Syndrome.

Studying Down syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
UMC Utrecht
Principal Investigator
Louis J Bont, MD, PhD
UMC Utrecht
Intervention
Immune response to Sars-CoV-2 vaccinations; including COVID-19 vaccin Moderna, Comirnaty (Pfizer) and Vaxzevria (AstraZeneca)(biological)
Enrollment
640 enrolled
Eligibility
12 years · All sexes
Timeline
2021 – 2023

Study locations (1)

Collaborators

ZonMw: The Netherlands Organisation for Health Research and Development · National Institute for Public Health and the Environment (RIVM) · Stichting Downsyndroom (SDS) · Sanquin Research & Blood Bank Divisions

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05145348 on ClinicalTrials.gov

Other trials for Down syndrome

Additional recruiting or active studies for the same condition.

See all trials for Down syndrome →

← Back to all trials